PUBLISHER: SkyQuest | PRODUCT CODE: 1360400
PUBLISHER: SkyQuest | PRODUCT CODE: 1360400
Global Vitreoretinal Surgery Devices Market size was valued at USD 2.07 billion in 2021 and is poised to grow from USD 2.19 billion in 2022 to USD 3.45 billion by 2030, growing at a CAGR of 5.84% in the forecast period (2023-2030).
The Global Vitreoretinal Surgery Devices Market encompasses surgical instruments and equipment used for treating disorders of the vitreous and retina. With a rising incidence of eye diseases and advancements in medical technology, the market is experiencing growth. Key players focus on innovative devices, such as vitrectomy machines, surgical lasers, and illumination tools. North America and Europe dominate the market due to healthcare infrastructure. The market is expected to continue its expansion with increasing awareness and aging populations contributing to the demand for these devices.
Top-down and bottom-up approaches were used to estimate and validate the size of vitreoretinal surgery devices and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
The global vitreoretinal surgery devices market is segmented on the basis of Product, End user and region. By Product, the market is segmented into Solar Photocoagulation Lasers, Vitreoretinal Packs, Illumination Devices, Vitrectomy Machines, Vitrectomy Probes, Others. By End user, the market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgery Centers, Others. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
The escalation of the worldwide elderly populace is a significant factor behind the surge in cases of age-related ocular ailments like macular degeneration and diabetic retinopathy, leading to an uptick in vitreoretinal surgeries. This demographic shift is propelling the requirement for vitreoretinal surgery devices, given their increasing importance in preserving visual well-being among the senior population.
The employment of vitreoretinal surgery devices and the relevant procedures can incur substantial expenses, covering machinery, disposables, and proficient healthcare staff. Such elevated expenditures might constrain the accessibility of these treatments, notably in areas with restricted medical budgets, thereby hindering the growth potential of the market.
Technological progress and inventive strides characterize the current state of the vitreoretinal surgery devices market. The integration of advanced technologies like robotic-assisted procedures, sophisticated visualization platforms, and less invasive surgical approaches is elevating the accuracy, productivity, and patient results. This wave of innovations appeals to medical professionals and patients alike, stimulating the acceptance of sophisticated devices renowned for their heightened safety and effectiveness.